The effect of L-5-hydroxytryptophan alone and in combination with a decarboxylase inhibitor (Ro-4-4602) in depressive patients.
D000328:Adult; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012701:Serotonin / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D010919:Placebos; D012701:Serotonin; D001545:Benserazide